15 results
·
22ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
MyoCycle Home, MyoCycle Pro
FDA 510(k)
FDA Class 2
·Neurology
EarQ
FDA UDI
Oticon A/S·05707131318596·G50, MRITE 312 2.4G NFM PB C044 EARQ
Millennium
FDA UDI
Avalign Technologies, Inc.·00190776163860·VAN BUREN URETH SNDS FR
Medline/MMS Sales
FDA UDI
MEDLINE INDUSTRIES, INC.·20080196984340·CIRCUIT-ADULT ANESTHESIA
SCHWERT
FDA UDI
A. Schweickhardt GmbH & Co. KG·E8961701320·Osteotome
concav...
Medline Industries, Inc.
FDA UDI
MEDLINE INDUSTRIES, INC.·10080196984343·CIRCUIT-ADULT ANESTHESIA
IN-OVATION® C
FDA UDI
DENTSPLY SIRONA ORTHODONTICS INC.·D807K100132611·IN-OVATION® C Roncone 022 U3-3 CS HK
IN-OVATION® C
FDA UDI
DENTSPLY SIRONA ORTHODONTICS INC.·D807K100132101·IN-OVATION® C Base Rx 022 U3-3 CS HK
MUSE CARDIOLOGY INFORMATION SYSTEM
FDA 510(k)
FDA Class 2
·Cardiovascular
TRIPORE, MODELS HA, BP90, BP15
FDA 510(k)
FDA Class 2
·Orthopedic
UNKNOWN KNEE
FDA Adverse Event
Other
·ENCORE MEDICAL, L.P.·Product code JWH·June 22, 2011
OMNIPOD INSULIN PUMP
FDA Adverse Event
Injury
·INSULET CORP·Product code LZG·June 6, 2013
CLINITEK STATUS+
FDA Adverse Event
Malfunction
·SIEMENS HEALTHCARE DIAGNOSTICS·Product code JIL·October 14, 2014
Allura CV20, system code 722031
FDA Enforcement
Class II
·Terminated·Philips North America, LLC·March 25, 2020
Merlin PCS Programmer software model 3330, used with Confirm Rx Insertable Cardiac Monitor (ICM), Model DM3500, Sterile. The firm name on the label of the ICM is St. Jude Medical Cardiac Rhythm Management Division, Sylmar, CA. - Product Usage: The Confirm Rx insertable cardiac monitor is designed to detect arrhythmias and wirelessly transmit data to the Merlin.net Patient Care Network. The Confirm Rx ICM is indicated for the monitoring and diagnostic evaluation of patients who experience unexplained symptoms such as: dizziness, palpitations, chest pain, syncope, and shortness of breath, as well as patients who are at risk for cardiac arrhythmias. It is also indicated for patients who have been previously diagnosed with atrial fibrillation or who are susceptible to developing atrial fibrillation.
FDA Enforcement
Class II
·Terminated·St Jude Medical, Cardiac Rhythm Management Division·January 22, 2020